• Home
  • About
  • Diagnostics
    • Ophthalmological
      • Overview
      • IgE Test
      • Lactoferrin Test
    • COVID-19 Testing Research
    • Other Areas
      • Oncological Diagnostics
      • New Test Development
  • Investors
    • Company Info
    • News
    • Media
    • Press Releases
    • SEC Filings
    • Corporate Governance
  • Contact

AXIM Launches New Eye Care Website; Establishes Platform for Commercialization

by IR Team | Jun 2, 2022 | Press Release

AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface diseases, today announced the launch of its new mobile-optimized website designed to provide doctors, researchers...

About

Diagnostics

Investors

Contact

Success!

Subscribe

  • Follow
  • Follow